Novo Nordisk A/S

Trump deals with Lilly, Novo Nordisk could broaden obesity drug access

Read more

Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle

Read more

Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices

Read more

Wegovy, Ozempic maker Novo Nordisk Q3 earnings

Read more

What’s next for the weight loss drug market: pills, rivals, insurance

Read more

Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments

Read more

Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill

Read more

Obesity pills from Eli Lilly, Novo Nordisk near US launch

Read more

Stoxx 600, FTSE, DAX, data

Read more

Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug

Read more